Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Ovarian Neoplasms 3Neoplasms 3Glioblastoma 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Solid Tumors 1Solid Tumor 1Small Cell Lung Carcinoma 1Sarcoma 1Neuroectodermal Tumors 1Nervous System Diseases 1Neoplasms by Site 1Neoplasms by Histologic Type 1Head and Neck Neoplasms 1HER2-negative Breast Cancer 1Gliosarcoma 1For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1Esophageal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Astrocytoma 1Advanced Malignant Solid Neoplasm 1Advanced Malignancies 1

Interventions

ponatinib 2pembrolizumab 2napabucasin 2ficlatuzumab 2entinostat 2Gemcitabine 2Bortezomib 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tetulomab tetraxetan lu-177 1siltuximab 1ruxolitinib 1pralsetinib 1pamiparib 1nirogacestat 1interferon gamma-1b 1denileukin diftitox 1bosutinib 1blinatumomab 1Vorinostat 1Trabectedin 1Radiation 1Oncolytic Virotherapy 1Lutetium 1Leucovorin 1Irinotecan 1Interferon-gamma 1Immunotherapy 1Imatinib Mesylate 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms by Histologic Type × pamiparib × Clear all
NCT03150862 2025-02-04

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

BeiGene

Phase 1/2 Completed
116 enrolled 31 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡